QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $5.78M invested in Qualigen Therapeutics in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.49M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.63M
2
+$1.48M
3
+$846K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$778K
5
AC
Armistice Capital
New York
+$665K

Top Sellers

1
-$16K
2
-$11K
3
-$7K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$7K
5
Millennium Management
Millennium Management
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.63M
2
$1.56M
3
$980K
4
$778K
5
$665K
6
$42K
7
$33K
8
$27K
9
$16K
10
$11K
11
$10K
12
$8K
13
$5K
14
$5K
15
$4K
16
$4K
17
–
18
–
19
–
20
–